0001104659-22-001644 4 1 20220103 20220105 20220105 White Mark K. 0001786183 4 34 001-39202 22513192 227 7TH AVENUE NE ST. PETERSBURG FL 33701 Annovis Bio, Inc. 0001477845 2834 262540421 DE 1231 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 QR Pharma, Inc. 20091202 4 1 tm221949-6_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-01-03 0 0001477845 Annovis Bio, Inc. ANVS 0001786183 White Mark K. C/O ANNOVIS BIO, INC. 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 1 0 0 0 Stock Option (right to buy) 19.78 2022-01-03 4 A 0 8000 0 A 2032-01-03 Common Stock 8000 8000 D The stock option shall vest in eight consecutive quarterly installments of 1,000 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024. /s/ Jeffrey McGroarty, Attorney-in-Fact for Mark White 2022-01-05